Unknown

Dataset Information

0

Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.


ABSTRACT: There are no available vaccines for dengue, the most important mosquito-transmitted viral disease. Mechanistic studies with anti-dengue virus (DENV) human monoclonal antibodies (hMAbs) provide a rational approach to identify and characterize neutralizing epitopes on DENV structural proteins that can serve to inform vaccine strategies. Here, we report a class of hMAbs that is likely to be an important determinant in the human humoral response to DENV infection. In this study, we identified and characterized three broadly neutralizing anti-DENV hMAbs: 4.8A, D11C, and 1.6D. These antibodies were isolated from three different convalescent patients with distinct histories of DENV infection yet demonstrated remarkable similarities. All three hMAbs recognized the E glycoprotein with high affinity, neutralized all four serotypes of DENV, and mediated antibody-dependent enhancement of infection in Fc receptor-bearing cells at subneutralizing concentrations. The neutralization activities of these hMAbs correlated with a strong inhibition of virus-liposome and intracellular fusion, not virus-cell binding. We mapped epitopes of these antibodies to the highly conserved fusion loop region of E domain II. Mutations at fusion loop residues W101, L107, and/or G109 significantly reduced the binding of the hMAbs to E protein. The results show that hMAbs directed against the highly conserved E protein fusion loop block viral entry downstream of virus-cell binding by inhibiting E protein-mediated fusion. Characterization of hMAbs targeting this region may provide new insights into DENV vaccine and therapeutic strategies.

SUBMITTER: Costin JM 

PROVIDER: S-EPMC3536401 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3466914 | BioStudies
2015-01-01 | S-EPMC4620467 | BioStudies
2011-01-01 | S-EPMC3119640 | BioStudies
2014-01-01 | S-EPMC3958310 | BioStudies
2012-01-01 | S-EPMC3250511 | BioStudies
2019-01-01 | S-EPMC6839414 | BioStudies
2013-01-01 | S-EPMC3573116 | BioStudies
1000-01-01 | S-EPMC4248927 | BioStudies
2013-01-01 | S-EPMC3870244 | BioStudies
2019-01-01 | S-EPMC6838341 | BioStudies